Merrimack Pharmaceuticals
MACK
$14.68
Share price
0.00%
Change (1 day)
16.42%
Change (1 year)
Categories
Market capitalization of Merrimack Pharmaceuticals (MACK)
Market cap: $0.21 Billion
As of April 2024 Merrimack Pharmaceuticals has a market cap of $0.21 Billion. This makes Merrimack Pharmaceuticals the world's 6865th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Merrimack Pharmaceuticals from 2012 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.21 B | 11.08% |
| 2023 | $0.19 B | 24.96% |
| 2022 | $0.15 B | 193.09% |
| 2021 | $52.43 M | -43.12% |
| 2020 | $92.18 M | 118.73% |
| 2019 | $42.14 M | -18.17% |
| 2018 | $51.5 M | -62.31% |
| 2017 | $0.13 B | -74.16% |
| 2016 | $0.52 B | -42.23% |
| 2015 | $0.91 B | -24.08% |
| 2014 | $1.20 B | 120.6% |
| 2013 | $0.54 B | -6.34% |
| 2012 | $0.58 B |
End of Day market cap according to different sources
On Apr 18th, 2024 the market cap of Merrimack Pharmaceuticals was reported to be:
$0.21 Billion
$0.21 Billion
$0.21 Billion
$0.21 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $113.31 B | 53,017.49% | 🇫🇷 France |
 Geron GERN | $2.19 B | 929.64% | 🇺🇸 USA |
 Clovis Oncology CLVS | $11.77 M | -94.48% | 🇺🇸 USA |
 AVEO Oncology
AVEO | $0.52 B | 144.44% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $11.63 M | -94.55% | 🇺🇸 USA |